<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04280263</url>
  </required_header>
  <id_info>
    <org_study_id>2020 DP</org_study_id>
    <nct_id>NCT04280263</nct_id>
  </id_info>
  <brief_title>Caffeine Study for Pain Control Following Total Joint Replacement</brief_title>
  <official_title>A Prospective Double Blinded Randomized Placebo Controlled Study of the Efficacy of Caffeine as an Analgesic Adjuvant for Acute Perioperative Pain Management Following Total Joint Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, double blinded, single center, randomized controlled study to evaluate the
      efficacy of caffeine in combination with acetyl salicylic acid (ASA) in the management of
      postoperative pain in patients undergoing total joint arthroplasty.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">February 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>post-operative pain</measure>
    <time_frame>2 weeks post-operative</time_frame>
    <description>pain will be recorded via Visual Analog Scale (VAS). The scale ranges from zero to 100 with zero being no pain and 100 being worst pain imaginable.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Caffiene</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive 150mg caffeine tablets to be taken twice per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caffeine</intervention_name>
    <description>caffeine tables containing 150mg caffeine will be provided to patients with instructions to take twice per day</description>
    <arm_group_label>Caffiene</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo oral tablet</intervention_name>
    <description>oral placebo tablets matching the caffeine tablets and will be provided to patients with instructions to take twice per day</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is older than 18 years old at the time of the surgery.

          -  Patient is treated by Rothman Orthopaedics institute and is scheduled for the surgical
             procedure at AtlantiCare Regional Medical Center.

          -  Patient is undergoing total hip or total knee arthroplasty.

          -  Patient has the diagnosis of Osteoarthritis of the hip or the knee, or other
             noninflammatory disease that results in joint damage to the hip or the knee.

        Exclusion Criteria:

          -  Patient has known history of opioid addiction and/or has taken opioids preoperatively.

          -  Patient has history of cardiac diseases that might be aggravated by the use of
             caffeine, as diagnosed by a cardiologist or demonstrated by an abnormal EKG.

          -  Patient has a known allergy to aspirin or caffeine.

          -  Patient has history of chronic pain that required the intervention of a pain
             management doctor.

          -  Patient has an active infection at the time of surgery (systemic or localized) or
             history of chronic infections that affected the lower extremities.

          -  Patient has history of cancer that would affect patient reported outcomes including
             pain.

          -  Patient has history of neuropathic pain or nerve degenerative disease.

          -  Patients undergoing revision surgery would be excluded.

          -  Patients who require alternate DTV prophylaxis other than ASA.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rothman Orthopaedics at Egg Harbor Township</name>
      <address>
        <city>Egg Harbor Township</city>
        <state>New Jersey</state>
        <zip>08234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 19, 2020</study_first_submitted>
  <study_first_submitted_qc>February 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2020</study_first_posted>
  <last_update_submitted>February 19, 2020</last_update_submitted>
  <last_update_submitted_qc>February 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

